RxDoctor Payments Data

Timothy Bothwell, MD

Family Medicine · Harlingen, TXNPI 1780680850

Payments from drug & device makers

$1,047in general payments, 2019–2025

Across 81 payments — averaging $12.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$252
  • Pfizer$137
  • Novo Nordisk$124
  • Dexcom, Inc.$70
  • Exact Sciences$68
  • GSK$67
  • plus $328 from 18 others

What the payments were for

  • Food & beverage$1,047100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,047 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$92,370
Medicare patients
194
Services billed
1,952

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin107$109,883
MounjaroTirzepatide72$78,841
EliquisApixaban112$72,579
OzempicSemaglutide59$65,195
Trelegy ElliptaFluticasone/Umeclidin/Vilanter73$53,377
RybelsusSemaglutide17$25,749
XareltoRivaroxaban19$20,556
Lagevrio (Eua)Molnupiravir21$12,647
TrulicityDulaglutide13$11,292
LinzessLinaclotide18$10,212
MyrbetriqMirabegron20$8,914
RestasisCyclosporine12$8,742
Tresiba Flextouch U-100Insulin Degludec16$7,704
Combivent RespimatIpratropium/Albuterol Sulfate11$7,681
LivaloPitavastatin Calcium13$6,205

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$21$117,564118 claims
Novo NordiskOzempic, Rybelsus$124$90,94376 claims
Lilly USA, LLCMounjaro, Trulicity$252$90,13385 claims
PfizerEliquis$137$72,579112 claims
GSKTrelegy Ellipta$67$53,37773 claims
Johnson & JohnsonXarelto$26$20,55619 claims
AbbVieLinzess, Restasis$18$18,95530 claims
Astellas Pharma US IncMyrbetriq$17$8,91420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Harlingen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →